|What would a similar chart from the pharma world look like?|
Image credit: Falk & Rogers, Harvard/Kennedy School of Government
It would be really interesting (to me, anyway) to know how many people are voluntarily leaving the pharmaceutical and/or biotech worlds. Where are they going (and why), I wonder? I remember a very promising young bench chemist from my Big Pharma days who decided (months after they were given an internal research award) to start over and head off to the intellectual property world. I sincerely hope that gave the senior management something to think about.
What would be my top 4? Job stability, ability to 'make a difference', company bureaucracy, the outlook for the industry easily come off the top of my head. Readers?
While I don't doubt that the most of the reasons are fairly obvious or well-picked over, it would be a good idea for someone in this industry (or ACS, as if they didn't have enough to do) to find out the numbers, track these folks down and interview them. Scientific data (or pseudo-scientific data) would be enough, I'd think, to end a lot of old arguments and start a lot of new ones.